0001567619-22-014311.txt : 20220721
0001567619-22-014311.hdr.sgml : 20220721
20220721175056
ACCESSION NUMBER: 0001567619-22-014311
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220720
FILED AS OF DATE: 20220721
DATE AS OF CHANGE: 20220721
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Eichorn Laura G.
CENTRAL INDEX KEY: 0001861067
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40604
FILM NUMBER: 221097998
MAIL ADDRESS:
STREET 1: IMAGO BIOSCIENCES, INC.
STREET 2: 329 OYSTER POINT BLVD. 3RD FL
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Imago BioSciences, Inc.
CENTRAL INDEX KEY: 0001623715
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 454915810
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 329 OYSTER POINT BLVD., 3RD FLOOR
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (415) 529-5055
MAIL ADDRESS:
STREET 1: 329 OYSTER POINT BLVD., 3RD FLOOR
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc1.xml
FORM 4
X0306
4
2022-07-20
0
0001623715
Imago BioSciences, Inc.
IMGO
0001861067
Eichorn Laura G.
C/O IMAGO BIOSCIENCES, INC.
329 OYSTER POINT BLVD, 3RD FLOOR
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
See Remarks
Common Stock
2022-07-20
4
M
0
1000
2.52
A
208737
D
Common Stock
2022-07-20
4
S
0
1000
18
D
207737
D
Stock Option (Right to Buy)
2.52
2022-07-20
4
M
0
1000
0.00
D
2021-01-01
2027-03-28
Common Stock
1000
100956
D
Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
Chief Operating Officer and CFO
/s/ Hugh Rienhoff, as Attorney-in-fact for Laura Eichorn
2022-07-21